Adam Inche

Chief Executive Officer & Founder of Lentitek

π—¦π—£π—˜π—”π—žπ—˜π—₯ π—¦π—£π—’π—§π—Ÿπ—œπ—šπ—›π—§: 𝗔 𝗀&𝗔 π—ͺπ—œπ—§π—› 𝗔𝗗𝗔𝗠 π—œπ—‘π—–π—›π—˜

Next up in our speaker spotlight series is Adam Inche, Chief Executive Officer & Founder of Lentitek – a company dedicated to increasing ATMP accessibility by enhancing quality and yield of lentiviral vectors.

Ahead of Adam’s panel session at Advanced Therapeutics Integrates North – Strength in Numbers – we talked about what he’s looking forward to at the event, challenges and opportunities in ATMP development, and why collaboration is crucial.

Adam Inche
Life Science Integrates
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.